VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $115,000 | +11400.0% | 31,250 | +31150.0% | 0.01% | – |
| Q2 2018 | $1,000 | 0.0% | 100 | -90.9% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -98.9% | 1,100 | -96.8% | 0.00% | -100.0% |
| Q3 2017 | $87,000 | +85.1% | 34,300 | +82.6% | 0.00% | +200.0% |
| Q4 2016 | $47,000 | -84.4% | 18,786 | -40.0% | 0.00% | -92.9% |
| Q3 2016 | $301,000 | +4200.0% | 31,316 | +2079.3% | 0.01% | – |
| Q2 2016 | $7,000 | +75.0% | 1,437 | -90.3% | 0.00% | – |
| Q1 2016 | $4,000 | -60.0% | 14,800 | +106.8% | 0.00% | -100.0% |
| Q4 2015 | $10,000 | – | 7,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |